These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2290338)

  • 1. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
    Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
    Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
    Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
    Chuchalin AG; Tsoĭ AN; Zaĭtseva TM; Titova EV; Medani SM; Smirnov MV; Kaziakhmedov EA
    Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of the theophylline concentration in the saliva and the blood serum in patients with a broncho-obstructive syndrome].
    Tsoĭ AN; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1994; 66(8):42-4. PubMed ID: 7985153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
    Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
    Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
    Andrasch R; Schmitz-Schumann M
    Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy using delayed-action theophylline].
    Ulmer WT; Zimmermann I
    Fortschr Med; 1982 Nov; 100(42):1973-6. PubMed ID: 7152431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
    Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 17. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A; von Wichert P
    Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D; Cuglituri G; Rossini L; Bonfardeci G
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.